-
The FDA is pushing drugmakers to do a better job at finding the lowest effective dose. One group is planning a study to test whether lower doses of two new drugs will work for breast cancer that has spread.
-
To drive down costs, insurers are delivering high-priced infusion drugs via third-party pharmacies. Hospitals and clinics are trying to convince states to limit this practice, known as "white bagging."
-
The National Comprehensive Cancer Network says that nearly all the centers it surveyed late last month were dealing with shortages of carboplatin and cisplatin.
-
Cancer chemotherapy often means serious hair loss, but many patients may be spared that as the result of a new device that looks a little like a World War II aviator's cap.
-
Researchers say the test, which measures gene activity, can help avoid "overtreating" tumors that are not life-threatening. It might allow some patients to avoid radiation and chemotherapy.
-
Scientists hunting cures for cancer hope to find therapies with fewer side effects. But there's also new evidence that old-style chemotherapy sometimes helps gentler treatments work better.
-
For some cancers, chemotherapy and radiation may be the best - or only - treatments available. Yet there are times when the side effects of the treatment…